Somasundaram Subramaniam, M.D., MS
4.8 78 Ratings | 8 Comments

Somasundaram Subramaniam, M.D., MS

Accepting New Patients
Check if your insurance is accepted Accepts edit Doesn't Accept edit
Offers Video Visits
4.8 | 78 Ratings | 8 Comments

1221 Madison Street, Arnold Pavilion, Suite 200

1221 Madison Street, Arnold Pavilion, Suite 200, Seattle, WA 98104

Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, Arnold Pavilion, Suite 200
Seattle, WA 98104
Medical Groups & Affiliations
Swedish

Speaks: English

Are you covered?

Check to see if your insurance is accepted by this provider.
Please contact your insurance provider to confirm if your health plan is accepted.

About Somasundaram Subramaniam

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy.

Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford.

In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community.
Medical School

National University of Singapore

Residency

University of Hawaii

Fellowship

Stanford University

Professional Associations

American Society of Clinical Oncology

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology
Medical Oncology - Swedish Cancer Institute First Hill
1221 Madison Street, Arnold Pavilion, Suite 200
Seattle, WA 98104
Medical Groups & Affiliations
Swedish
Affiliated Locations

Swedish Cherry Hill
Swedish First Hill

Clinical Interests

  • Aids Related Malignancies
  • Anaplastic Meningioma
  • Atypical Meningioma
  • Bladder Cancer Genomics
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Cervical Cancer Genomics
  • Chemoradiation
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer
  • Colon Cancer Genomics
  • Colorectal Cancer
  • Colorectal Screening
  • Crizotinib
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Fibrous Meningioma
  • Gallbladder Cancer Genomics
  • Gastrointestinal (Gi) Cancer
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Genomics
  • Histiocytic Sarcoma
  • Immature Teratoma
  • Leukemia Genomics
  • Liver Cancer Genomics
  • Lung Cancer Genomics
  • Lymphedema Therapy
  • Lymphoma Genomics
  • Malignant Neoplasm Of Liver
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Mesothelioma
  • Metastatic Liver Cancer
  • Mucosal Melanoma
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Oral Complications Of Cancer
  • Oral Lesions
  • Pain Management
  • Pancreas Cancer
  • Pancreatic Cancer Genomics
  • Plasma Cell Dyscrasia
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rectal Cancer Genomics
  • Renal Cancer Genomics
  • Retroperitoneal Mass
  • Sarcoma Genomics
  • Side Effects Of Cancer Treatment
  • Skin Cancer Genomics
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer Genomics
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Thoracic Cancer
  • Thyroid Cancer Genomics
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Vaginal Melanoma
  • Virtual Care